Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma

Bortezomib: A novel chemotherapeutic agent for hematologic malignancies

(2008) Kyle N. Utecht et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Thalidomide for treatment of multiple myeloma: 10 years later

(2008) A. Palumbo et al.   BLOOD

Multiple myeloma

(2008) R. A. Kyle et al.   BLOOD

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature

(2008) A. A. Argyriou et al.   BLOOD

Factor Xa Binding to Annexin 2 Mediates Signal Transduction via Protease-Activated Receptor 1

(2008) Gourab Bhattacharjee et al.   CIRCULATION RESEARCH

Clinical Malignant Hematology

(2008) Paulette Mehta   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Interferon-γ Reduces Cell Surface Expression of Annexin 2 and Suppresses the Invasive Capacity of Prostate Cancer Cells

(2008) Claire Hastie et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The N-terminal Domain of Annexin 2 Serves as a Secondary Binding Site during Membrane Bridging

(2008) Malik Zibouche et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion

(2008) U. Rescher et al.   JOURNAL OF CELL SCIENCE

Lenalidomide for the Treatment of B-Cell Malignancies

(2008) Asher A. Chanan-Khan et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiple Myeloma Cancer Stem Cells

(2008) Carol Ann Huff et al.   JOURNAL OF CLINICAL ONCOLOGY

Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Drugs

(2007) William Bensinger   JOURNAL OF CLINICAL ONCOLOGY